Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among CKD patients at risk for progression
2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1 Diabetes
Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity
Inhaled Nicotine Disrupts Normal Heart Function
Effects seen in rats in recent study
Knowledge of Abdominal Aortic Calcification Results Improves Some CVD Risk Factors
Findings show no impact on fruit, veggie intake, but some improvement in cholesterol levels and cardiovascular risk scores
ASA: Fibrinogen-to-Albumin Ratio Is Risk Factor for Preeclampsia
FAR was one of only two markers that were significant in predicting both PE and PE with severe features
Poor Cardiovascular Health Linked to Composite of Poor Brain Health
Individuals with poor or intermediate cardiovascular health have increased risk for composite of stroke, dementia, late-life depression
Exposure to Inorganic Arsenic in Drinking Water Increases Cardiovascular Risk
Risk for ischemic heart disease elevated even at exposure levels below the current regulatory limit of 10 µg/L
FDA Appoints New Head of Medical Devices
By Ernie Mundell HealthDay ReporterWEDNESDAY, Oct. 23, 2024 (HealthDay News) — The U.S. Food and Drug Administration announced Tuesday that it has appointed Dr. Michelle Tarver to head its division …
Adult Hypertension Prevalence 47.7 Percent From August 2021 to August 2023
Hypertension increased with age, from 23.4 percent for those aged 18 to 39 years to 71.6 percent for those aged 60 years and older
Risk for Sudden Cardiac Death Elevated for Patients With Psychiatric Disorders
Highest rates of SCD seen for patients with schizophrenic disease; 10-year excess loss of life expected for 18-year-olds with psychiatric disorder